➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Johnson and Johnson
McKesson
McKinsey
Moodys

Last Updated: May 24, 2020

DrugPatentWatch Database Preview

ALPHATREX Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Alphatrex, and when can generic versions of Alphatrex launch?

Alphatrex is a drug marketed by Savage Labs and is included in three NDAs.

The generic ingredient in ALPHATREX is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.

Summary for ALPHATREX
Drug patent expirations by year for ALPHATREX
Synonyms for ALPHATREX
(11-beta,16-beta)-9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11.beta.,16.beta.)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
(11beta,16beta)-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthr
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
2-((2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-2,13,15-trimethyl-5-oxo -14-propanoyloxytetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl)-2-o xoethyl propanoate
5593-20-4
826Y60901U
9-Fluoro-11.beta.-hydroxy-16.beta.-methyl-3,20-dioxo-17-(propionyloxy)pregna-1,4-dien-21-yl propionate #
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-fluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate)
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17,21-dipropionate
9alpha-Fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 17,21-Dipropionate
9alpha-fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene- 17,21-diyl dipropionate
AB01274713_02
AB01274713-01
AB2000220
AKOS015969733
B3166
BDBM50421892
Beloderm
beta-Methasone 17,21-dipropionate
Betamethasone 17,21-dipropionate
BETAMETHASONE DIPROP
betamethasone dipropionat
BETAMETHASONE DIPROPIONATE
Betamethasone Dipropionate (Diprolene)
Betamethasone dipropionate (JP17/USP)
Betamethasone dipropionate [USAN:BAN:JAN]
Betamethasone dipropionate [USAN:USP:JAN]
betamethasone propionate
Betamethasone-17,21-dipropionate
Betamethasone-Dipropionate(Diprolene)
BRD-K58148589-001-03-6
BRN 3638108
C-22966
C28H37FO7
CAS-5593-20-4
CC-24614
CHEBI:31276
CHEMBL1200384
CIWBQSYVNNPZIQ-XYWKZLDCSA-N
component of Alphatrex (Salt/Mix)
component of Betasone (Salt/Mix)
CS-7549
D01637
Diproderm
Diprolene
Diprolene (TN)
Diprolene AF
Diprosis
Diprosone
Diprospan;Diprolene;Diprosone;Diprolene AF;Diprolene
DSSTox_CID_2672
DSSTox_GSID_22672
DSSTox_RID_76683
DTXSID2022672
EBD2157850
EINECS 227-005-2
en-17-yl propionate
HY-13571
KS-5303
LS-118474
Maxivate
NCGC00159360-02
NCGC00159443-01
NCGC00159443-02
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-.beta.,17,21-trihydroxy-16-.beta.-methyl-,17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-, 17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-,17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11.beta.,16.beta.)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16beta)
Psorion
Q4897349
Rinderon DP
Rinderon-DP (TN)
S 3440
S-3440
s1688
Sch 11460
Sch-11460
SCHEMBL7519
Sernivo
Sernivo (TN)
ST024761
Tox21_113343
UNII-826Y60901U
ZINC4212137

US Patents and Regulatory Information for ALPHATREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs ALPHATREX betamethasone dipropionate CREAM;TOPICAL 019138-001 Jun 26, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Savage Labs ALPHATREX betamethasone dipropionate LOTION;TOPICAL 070273-001 Aug 12, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Savage Labs ALPHATREX betamethasone dipropionate OINTMENT;TOPICAL 019143-001 Sep 4, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Johnson and Johnson
McKesson
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.